Medtronic Provision for Credit Losses increased by 55.6% to $28.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 55.6%, from $18.00M to $28.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests deteriorating credit quality or portfolio growth, while a decrease may indicate improved borrower health or more conservative lending.
This is an expense set aside to cover expected future losses on loans and credit card receivables. It reflects managemen...
Standard for all lenders and credit card issuers.
is_provision_for_credit_losses| Q3 '21 | Q3 '22 | Q3 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|
| Value | $15.00M | $15.00M | $21.00M | $18.00M | $28.00M |
| QoQ Change | — | +0.0% | +40.0% | -14.3% | +55.6% |
| YoY Change | — | +0.0% | +40.0% | -14.3% | +55.6% |